Detemir Energy Expenditure Study

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Type 2 Diabetes MellitusObesity
Interventions
DRUG

Insulatard

Insulatard insulin used as long-acting insulin for 16-week treatment phase of study.

DRUG

Detemir

Detemir insulin used as long-acting insulin in treatment phase of study.

Trial Locations (1)

GU2 7XX

Cedar Centre, Royal Surrey County Hospital, Guildford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

University of Surrey

OTHER

NCT00788840 - Detemir Energy Expenditure Study | Biotech Hunter | Biotech Hunter